Downstream Processing Featured Articles

1. Researchers Develop Method To Grow Artificial Tissues With Embedded Nanoscale sensors 8/26/2012

   A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.

2. Saint-Gobain Adds Large Clamps To Pure-Fit® Line 6/28/2012

   New Pure-Fit® TCL accommodates large diameter and thick wall tubing applications. Saint-Gobain Performance Plastics has expanded its line of innovative tube clamps with the introduction of the new Pure-Fit® TCL large tube clamp.

3. Researchers' Sequencing Of Human and Monkey Malaria Genomes Reveals Challenges, Opportunities In Battle Against Parasite 8/5/2012

   Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria.

4. Caliper's 'Lab On A Chip' Technology To Screen Neurocrine Assays 1/21/1999
   Caliper Technologies Corp. and Neurocrine Biosciences, Inc. are combining their drug discovery efforts to develop treatments for central nervous system and immune system diseases...
5. Pittcon 2013 Conference Tackles Life Sciences Challenges, Novel Research 2/7/2013

   Pittcon has always been the premiere venue for companies to launch new products and for scientists to present their latest research to a global audience.

6. Novartis To Start Construction Of New Biotechnology Facility In Singapore With An Investment Of Over USD 500 Million 10/31/2012

   ​Novartis announced recently the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture technology.

7. New Insights Into HIV Vaccine Protection Will Improve Drug Development 1/28/2013

   Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.

8. Researchers Identify Variations In Four Genes That Are Associated With An Increased Risk Of Colorectal Cancer 2/20/2013

   An international research team co-led by cancer prevention researcher Ulrike “Riki” Peters, Ph.D., M.P.H., and biostatistician Li Hsu, Ph.D., at Fred Hutchinson Cancer Research Center has identified variations in four genes that are linked to an increased risk of colorectal cancer.

9. Genetic Immunity Receives GMP Certification For In-House Manufacturing Facility 10/8/2012

   Genetic Immunity (OTCBB: PWRV) is pleased to announce the GMP approval of its manufacturing facility. The development of the GMP manufacturing process and the facility was financed from a $4 million grant received from the Hungarian Office for Innovation and Technology.

10. Vaccine And Antibiotics Stabilized So Refrigeration Is Not Needed 7/10/2012

    Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.